[1] WU JR, ZHANG B.Study on the successive changes of Chinese traditional pharmacovigilance theory[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2006, 3(5): 257-260. [2] ZHANG B, LIN ZJ, ZHANG XM.Pharmacovigilance of Chinese medicine: practice of cognition, application, prevention and reduce of drug toxity[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2017, 42(10): 2017-2020. [3] ZHOU RS, LU PW, CHEN JH, et al.Application of Adverse drug reaction of data mining in pharmacovigilance[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2024, 41(6): 864-870. [4] LI CJ.Researches on theory and application of adverse drug reaction signal detection[D]. Xi'an: The Fourth Military Medical University, 2008. [5] WANG LX, XIE YM, CHENG WX, et al.Analysis of adverse reaction risk signal of Xinyuan capsules based on national ADR monitoring spontaneous reporting system[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(10): 2310-2315. [6] ZHANG XM, LI F, ZHANG B, et al.Data-mining characteristics of adverse drug reactions and pharmacovigilance of Chinese patent drugs including Aconitum herbs[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 43(2): 216-221. [7] DING H, WU JY, TONG J, et al.Study on the acute toxicity and mechanism of Tripterygium Wilfordii Hook F.[J]. Journal of Chinese Herbal Medicine(中药材), 2004(2): 115-118. [8] HE YM, ZHONG QQ, WANG K, et al.Cardiotoxicity of Ephedra to rabbit model system[J]. Journal of Huazhong Agricultural University(华中农业大学学报), 2010, 29(4): 484-488. [9] DENG N, YI Y, LIANG AH, et al.Mechanism of nephrotoxicity of rhubarb in rats[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 43(13): 2777-2783. [10] QUAN YY, ZHOU YM, LIU MC, et al.Hepatotoxicity evaluation of eighteen components in Polygoni Multiflori Radix with Zebrafish (Danio rerio) model[J]. Natural Product Research and Development(天然产物研究与开发), 2018, 30(5): 744-752. [11] ZHOU Q, JIN RM, YAO GT.Preliminary study on Hepatocytes and Nephrocytes toxicity induced by Dayricine[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2012, 9(10): 580-583. [12] BABURIN I, VARKEVISSER R, SCHRAMM A, et al.Dehydroevodiamine and hortiamine, alkaloids from the traditional Chinese herbal drug Evodia rutaecarpa, are IKr blockers with proarrhythmic effects in vitro and in vivo[J]. Pharmacol Res, 2018, 131: 150-163. [13] GU SY, TANG LM, ZHANG WD.Evaluation method of nephrotoxicity of traditional Chinese medicine based on 3D organoids//Chinese Society of Toxicology, Professional Committee of Toxicology of Traditional Chinese Medicine and Natural Medicines. Proceedings of the Fourth (2019) Annual Academic Conference on Toxicology and Safety Evaluation of Traditional Chinese Medicine and Natural Medicines(中国毒理学会中药与天然药物毒理专业委员会. 中国毒理学会中药与天然药物毒理与安全性评价第四次(2019年)学术年会论文集)[C]. Haikou, 2019: 3. [14] XIE X, LIU M, YANG M, et al.Application status and thinking of network toxicology in traditional Chinese medicine research[J]. Journal of Chengdu University(Natural Science Edition)(成都大学学报自然科学版), 2024, 43(1): 1-6, 68. [15] ZHAO Z, DU JF, WANG QL, et al.An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro[J]. Food Chem Toxicol, 2023, 176: 113785. [16] CAO S.Study on hepatotxicity mechanism of Asarum power based on metabolomics and transcriptomics[D]. Wuhan: Hubei University of Chinese Medicine, 2020. [17] HE S, OU SP, YE LH, et al.Hepatotoxicity mechanism of Toosendan Fructus based on network pharmacology and molecular docking techniques[J]. Drugs & Clinic(现代药物与临床), 2023, 38(12): 2955-2964. [18] SHI L, LIU X, ZHANG B.Study on prevention of drug toxicity in pharmacovigilance thought of the compendium of materia medica[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(7): 404-410. [19] HUANG ZH, ZHAO ST, YANG SM, et al.Visual analysis of hot spots in traceability research of traditional Chinese medicine based on citespace[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology(世界科学技术-中医药现代化), 2021, 23(7): 2402-2409. [20] ZHANG B, ZHANG XM, LIN ZJ, et al.Series of group standards of technical specifications for revision of safety information in marketed Chinese patent medicine instruction[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2022, 47(2): 285-294. [21] LI C, RAO T, CHEN X, et al.HLA-B*35:01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans[J]. Hepatology, 2019, 70(1): 346-357. [22] Guidelines for safe use of polygoni multiflori radix[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(5): 961-966. [23] WU MF, SHI WZ, ZHAO ZG.Cimparison of domestic prescription pre-audit systems in China[J]. Central South Pharmacy(中南药学), 2019, 17(9): 1547-1552. [24] MA BB, ZHANG XM, ZHANG B, et al.Consideration of rational use of traditional Chinese medicine and pharmaceutical services for the elderly based on literature analysis[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(6): 595-599. [25] WANG XF, ZHANG XM, ZHANG B, et al.Pharmacovigilance and pharmamceutical care of traditional Chinese medicine based on ancient pediatric literature[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(6): 591-594, 609. [26] LYU JT, ZHANG XM, ZHANG B, et al.Chinese medicine pharmacovigilance and pharmaceutical care for progestational, pregnant and post-partum women based on ancient literature[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(6): 585-590. [27] ZHANG ZQ, ZHANG XM, ZHANG B, et al.Risk factors of liver injury in traditional Chinese medicine and TCM pharmacovigilance for medications against hepatic insufficiency[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(6): 600-604. [28] ZHU JF, YI XJ, ZHONG LK, et al.TCM theory and research progress on pharmacological effects of traditional Chinese medicine against doxorubicin-induced cardiotoxicity[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2022, 37(8): 4592-4598. [29] YIN YL, HU CJ, ZHANG XM, et al.Mining and validation of anti-adriamycin cardiotoxic effect of chicory extract[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(8): 858-865. [30] SA RN, ZHANG B, LIN ZJ, et al.Therapeutic effect of saffron against arrhythmia induced by doxorubicin in rats[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(8): 848-857. [31] ZHANG XM, LYU JT, ZHANG B, et al.Risk assessment and pre-warning of injection within Bufonis Veneum in the treatment of liver cancer[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(5): 469-474, 492. [32] WANG T, ZHENG MJ, LIU HL, et al.Current applications of artificial intelligence in pharmacovigilance in the USA and implications[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(10): 1129-1133. [33] Journal News.PubHive launches AI-driven pharmacovigilance workflow[J]. Data Analysis and Knowledge Discovery(数据分析与知识发现), 2023, 7(12): 141. |